SKYLA belongs to the LITE-ON Corporation Group (TW STOCK: 2301), is dedicated to developing innovative medical devices focused on analyzers with versatile & multiplexing platforms for POCT of IVD.
Skyla has been marketing to 86 countries globally since 2011. With advanced R&D technology, our products have achieved major certifications, FDA, CE, CFDA, TFDA, etc. We strive to keep providing quality products & service to win together with partners.